Migraine is a recurring primary headache condition that affects the largest number of people among the many headache types, with 1 in 10 people suffering from migraine. Sufferers experience an untimely swelling and pain in the head, mainly centered around the temples to the eyes. Flashes of light, blurred vision, numbness of the limbs and other aura are often present before the attack, and gradually aggravated by a throbbing and pulsating pain. There are many triggering factors for migraine, such as insomnia, weakness, illness, stress, bad hobbies or emotions, etc., which may trigger headaches in patients. Migraine is very harmful, in addition to the damage that can be caused by the disease itself, it can lead to a decrease in the patient’s ability to learn and work, a decrease in the quality of life, and may even result in cerebral white matter lesions, cognitive decline, and posterior circulation asymptomatic cerebral infarction. Migraine is also often co-morbid with anxiety and depression. Modern clinical research has confirmed that migraine is a vascular neurological disease, which is mainly triggered by the adhesion and accompaniment between the nerves and blood vessels, as well as entanglement and compression. Neurosurgery experts said that traditional drugs, acupuncture, massage and other treatments are not cured because the root cause of the disease is not found. The introduced microvascular decompression technique is to target the “pain points” of blood vessels and nerves that cause migraine, and use minimally invasive technology to directly attack the lesion, find the closely connected nerves and blood vessels, and then isolate the responsible blood vessels under the microscope, so as to reduce the stimulation of the nerves caused by vascular dilatation, and thus to achieve the goal of completely curing migraine.